EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico

José Arturo Hernández-Ibarra iD, Tomás Rafael Mercado-Torres, José Raúl Ruiz-Ruiz, Carla M Román-Montes, Sandra Rajme-López iD, A Martínez-Guerra iD, Fernanda González-Lara, Héctor O Rivera-Villegas, Zohar Guy, Adriana Del C Roblero-Abadía, Alfredo Ponce de-León iD, Jose Sifuentes-Osornio iD und 1 weitere

PLOS One · 20.03.2026 · 21 (3) · e0338570

DOI: 10.1371/journal.pone.0338570 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 20.03.2026. Verfasst von José Arturo Hernández-Ibarra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición, "Salvador Zubirán", Mexico City, Mexico. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The management of Tuberculosis (TB) in patients with chronic kidney disease (CKD) presents unique challenges, including an immunosuppressive state, altered drug pharmacokinetics, and limited access to single-drug formulations in our setting. There is a scarcity of real-world evidence on TB outcomes in this population in Latin America. Our study aimed to compare mortality, cure, and relapse rates between TB patients with ACKD and without ACKD.

Methods

We conducted an observational-analytical study of all patients aged ≥18 years with microbiologically or histologically confirmed TB between 2013 and 2024. Patients with ACKD (GFR < 30 mL/min/1.73 m² were compared against age- and sex-matched non-ACKD (GFR ≥ 30 mL/min/1.73 m²) patients. Due to differential HIV distribution, we also performed a sensitivity analysis excluding HIV-positive patients. The primary outcome was all-cause mortality at 1 year. Outcomes were compared using the Chi-squared and Mann-Whitney U tests, as well as logistic regression.

Results

A total of 51 patients with tuberculosis were included (17 with ACKD, 34 without ACKD). CKD was caused by lupus or diabetes in 29% of patients each. Most CKD patients (68%) received a local pragmatic alternating regimen. One-year all-cause mortality was 18% in both groups (p > 0.999), and TB-related mortality was 9% in the control group, vs 0% in the ACKD group. The cure rate was similar between groups (ACKD: 88% vs. non-ACKD: 82%; p = 0.586). No relapses occurred. In a sensitivity analysis excluding HIV-positive patients (n = 44), findings were consistent with the primary analysis, with no significant difference in mortality between groups. Due to the low event rate, we conducted a bivariate analysis in an exploratory fashion and did not perform a multivariate analysis.

Conclusions

In this Mexican small cohort, ACKD didn’t significantly worsen TB outcomes compared with non-ACKD patients. An local pragmatic alternating regimen was used without apparent harm. These preliminary findings are limited by small sample size, limited statistical power, and lack of pharmacokinetic validation. Larger studies with drug monitoring are needed to optimize treatment for this vulnerable group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicTuberculosisHumansFemaleMexicoTertiary Care CentersMiddle AgedMaleAdultAntitubercular AgentsRecurrence

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición, "Salvador Zubirán", Mexico City, Mexico.
  • Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, "Salvador Zubirán", Mexico City, Mexico.
  • General Direction, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.

ORCID-Profile: José Arturo Hernández-Ibarra, Sandra Rajme-López, A Martínez-Guerra, Alfredo Ponce de-León, Jose Sifuentes-Osornio, Karla M Tamez-Torres

Zitieren

APA

Hernández-Ibarra, J. A., Mercado-Torres, T. R., Ruiz-Ruiz, J. R., Román-Montes, C. M., Rajme-López, S., Martínez-Guerra, A., González-Lara, F., Rivera-Villegas, H. O., Guy, Z., Roblero-Abadía, A. D. C., de-León, A. P., Sifuentes-Osornio, J., & Tamez-Torres, K. M. (2026). Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico. PLOS One, 21(3), e0338570. https://doi.org/10.1371/journal.pone.0338570

Vancouver

Hernández-Ibarra JA, Mercado-Torres TR, Ruiz-Ruiz JR, Román-Montes CM, Rajme-López S, Martínez-Guerra A, et al. Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico. PLOS One. 2026;21(3):e0338570. doi:10.1371/journal.pone.0338570

BibTeX
@article{HernndezIbarra2026,
  author = {Hernández-Ibarra, José Arturo and Mercado-Torres, Tomás Rafael and Ruiz-Ruiz, José Raúl and Román-Montes, Carla M and Rajme-López, Sandra and Martínez-Guerra, A and González-Lara, Fernanda and Rivera-Villegas, Héctor O and Guy, Zohar and Roblero-Abadía, Adriana Del C and de-León, Alfredo Ponce and Sifuentes-Osornio, Jose and Tamez-Torres, Karla M},
  title = {Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0338570},
  doi = {10.1371/journal.pone.0338570}
}
Kostenlos starten →